검색결과 : 7건
| No. | Article |
|---|---|
| 1 |
Downregulated CDKN1C/p57(kiP2) drives tumorigenesis and associates with poor overall survival in breast cancer Qiu Z, Li YH, Zeng BL, Guan XQ, Li HZ Biochemical and Biophysical Research Communications, 497(1), 187, 2018 |
| 2 |
Utility of fluorescence in situ hybridization for ploidy and p57 immunostaining in discriminating hydatidiform moles Chen KH, Hsu SC, Chen HY, Ng KF, Chen TC Biochemical and Biophysical Research Communications, 446(2), 555, 2014 |
| 3 |
Development of mice without Cip/Kip CDK inhibitors Tateishi Y, Matsumoto A, Kanie T, Hara E, Nakayama K, Nakayama KI Biochemical and Biophysical Research Communications, 427(2), 285, 2012 |
| 4 |
p57(Kip2) is expressed in quiescent mouse bone marrow side population cells Umemoto T, Yamato M, Nishida K, Yang J, Tano Y, Okano T Biochemical and Biophysical Research Communications, 337(1), 14, 2005 |
| 5 |
Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells Nakano N, Urasawa K, Takagi Y, Saito T, Kaneta S, Ishikawa S, Higashi H, Tsutsui H, Hatakeyama M, Kitabatake A Biochemical and Biophysical Research Communications, 338(3), 1661, 2005 |
| 6 |
Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain Weitzdoerfer R, Fountoulakis M, Lubec G Biochemical and Biophysical Research Communications, 293(2), 836, 2002 |
| 7 |
A pro-apoptotic effect of the CDK inhibitor p57 (Kip2) on staurosporine-induced apoptosis in HeLa cells Samuelsson MKR, Pazirandeh A, Okret S Biochemical and Biophysical Research Communications, 296(3), 702, 2002 |